ThomasMaclayOrmistonMD

PubMed

• 389 citations
  Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.
  Shelley R. Salpeter, Judith M. E. Walsh, Thomas M. Ormiston, Elizabeth Greyber, N. S. Buckley, Edwin E. Salpeter> ;Diabetes, Obesity & Metabolism. 2006 Sep 1
• 44 citations
  Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs.
  Shelley R. Salpeter, Peter W. Gregor, Thomas M. Ormiston, Richard P. Whitlock, Parminder Raina, Lehana Thabane, Eric J. Topol> ;The American Journal of Medicine. 2006 Jul 1
• 347 citations
  Meta-Analysis: Effect of Long-Acting β-Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths
  Shelley R. Salpeter, Nicholas S. Buckley, Thomas M. Ormiston, Edwin E. Salpeter> ;Annals of Internal Medicine. 2006 Jun 20
• 176 citations
  Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.
  Shelley R. Salpeter, Judith M. E. Walsh, Elizabeth Greyber, Thomas M. Ormiston, Edwin E. Salpeter> ;Journal of General Internal Medicine. 2004 Jul 1
• 406 citations
  Cardiovascular Effects of β-Agonists in Patients With Asthma and COPD: A Meta-Analysis
  Shelley R. Salpeter, Thomas M. Ormiston, Edwin E. Salpeter> ;Chest. 2004 Jun 1
• 86 citations
  Meta-Analysis: Respiratory Tolerance to Regular β2-Agonist Use in Patients with Asthma
  Shelley R. Salpeter, Thomas M. Ormiston, Edwin E. Salpeter> ;Annals of Internal Medicine. 2004 May 18
• 100 citations
  Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
  Shelley R. Salpeter, Thomas M. Ormiston, Edwin E. Salpeter, Phillippa Poole, Christopher J Cates> ;Respiratory Medicine. 2003 Oct 1
• 19 citations
  Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice.
  Ormiston Tm, Salpeter> ;Heart Failure Monitor. 2003 Jan 1
• 169 citations
  Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.
  Shelley R. Salpeter, Thomas M. Ormiston, Edwin E. Salpeter> ;Annals of Internal Medicine. 2002 Nov 5
• 8 citations
  Hormonal changes with cholesterol reduction: a double-blind pilot study.
  T. Ormiston, Owen M. Wolkowitz, Victor I. Reus, Ronald C. Johnson, F. Manfredi> ;Journal of Clinical Pharmacy and Therapeutics. 2004 Feb 1
• Cardioselective beta-blockers for chronic obstructive pulmonary disease.
  Salpeter, S. S., Ormiston, T., Salpeter, E., Poole, P., Cates, C.> ;Cochrane Database Syst Rev. 2002
• Cardioselective beta-blockers for reversible airway disease.
  Salpeter, S., Ormiston, T., Salpeter, E.> ;Cochrane Database Syst Rev. 2002
• Cardioselective beta-blocker use in patients with reversible airway disease.
  Salpeter, S., Ormiston, T., Salpeter, E.> ;Cochrane Database Syst Rev. 2001
• Cardioselective beta-blockers for reversible airway disease.
  Salpeter, S., Ormiston, T., Salpeter, E.> ;Cochrane Database Syst Rev. 2002
• Cardioselective beta-blockers for chronic obstructive pulmonary disease.
  Salpeter, S., Ormiston, T., Salpeter, E.> ;Cochrane Database Syst Rev. 2005
• Join now to see all